Supernus Pharmaceuticals
SUPN
#5037
Rank
A$2.61 B
Marketcap
A$44.90
Share price
1.78%
Change (1 day)
-36.01%
Change (1 year)

Supernus Pharmaceuticals (SUPN) - Total assets

Total assets on the balance sheet as of June 2026 : A$2.15 Billion

According to Supernus Pharmaceuticals 's latest financial reports the company's total assets are A$2.15 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Supernus Pharmaceuticals - Total assets on balance sheet (from 2009 to 2026)

Total assets by year

Year Total assets Change
2025-12-31A$2.16 B-1.4%
2024-12-31A$2.19 B17.28%
2023-12-31A$1.87 B-25.04%
2022-12-31A$2.50 B7.38%
2021-12-31A$2.32 B19.11%
2020-12-31A$1.95 B18.04%
2019-12-31A$1.65 B19.4%
2018-12-31A$1.38 B155.29%
2017-12-31A$0.54 B26.6%
2016-12-31A$0.42 B65.86%
2015-12-31A$0.25 B54.92%
2014-12-31A$0.16 B34.31%
2013-12-31A$0.12 B37.58%
2012-12-31A$90.44 M72.6%
2011-12-31A$52.4 M13.23%
2010-12-31A$46.27 M-47.97%
2009-12-31A$88.94 M-18.65%
2008-12-31A$0.10 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Johnson & Johnson
JNJ
A$298.26 B 13,724.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$166.83 B 7,632.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$223.70 B 10,268.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$134.11 B 6,116.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Zogenix
ZGNX
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
United Therapeutics
UTHR
A$10.90 B 405.57%๐Ÿ‡บ๐Ÿ‡ธ USA